

Revita® is an amniotic allograft produced by SurgicalBioFix in a purpose-built facility in Brisbane. It is produced from placentas donated by women who have consented to the
donation.
Revita® is a Class 2 Human Biologic and is considered an “advanced wound care product.” Each batch of Revita® is produced and rigorously tested to ensure it is free of any biological contamination and is a sterile product.
Revita® is the only allograft of its type produced and approved for use in Australia.
SurgicalBioFix holds all relevant licences from, and product listings with the Australian Therapeutic Goods Administration (TGA). Current permitted use of Revita® is in treatment of non-healing acute and chronic wounds, burns, and other dermal defects (DFUs, VLUs etc). Proteins, growth factors and collagens are naturally occurring in the human placenta. Wound
closure is enhanced with Revita® and usually achieves faster results than legacy treatments, even with wounds that have been present long-term. This shortened timeframe alone will not only bring better outcomes in healing the wound, but it also often provides pain relief and overall better quality of life for the patient.
Although Revita® is relatively new to the Australian Healthcare scene, Australian patients and clinicians achieve often surprising and unexpected results and are realising the benefits in using this allograft product. Enquire here about how to access this product for your hard to heal wound.
Read more about the product here https://www.surgicalbiofix.com



EmoLED Light therapy
EmoLED light treatment can be used on a broad range of wounds, including chronic skin lesions such as ulcers of the lower limbs (venous, arterial and mixed ulcers), inflammatory ulcers (from rheumatic diseases, scleroderma), diabetic foot and pressure ulcers, skin lesions with massive tissue loss such as burns and trauma wounds, surgical wound dehiscence, and dermatological disorders such as atopic dermatitis.
The therapeutic mechanism of blue light: Photobiomodulation.
“The therapeutic effect of light occurs thanks to the presence of endogenous molecules in an organism’s tissues that are capable of absorbing light. The energy conveyed by the light spectrum is absorbed by these naturally existing elements, known as “chromophores”, and is used to promote chemical reactions or produce conformational changes in certain biomolecules.
This process translates into beneficial therapeutic effects such as reduction of pain and inflammation. Each chromophore has a different absorption spectrum and therefore a different sensitivity to various wavelengths which, once absorbed by tissues, can produce varying photophysical and photochemical effects.
EmoLED has developed a photobiomodulation-based therapy for skin lesions that uses specific wavelengths of visible light spectrum in the blue range. Blue light is absorbed by electron transport chain enzymes and by flavoproteins. Its therapeutic effects include resolving inflammation, reducing pain and stimulating tissue regeneration, as observed in preclinical and clinical studies.
Photobiomodulation with blue light, a therapy that can stimulate inflammatory phase transition, can contribute to the resolution of wounds with a delayed or not-completed healing process. “
Sonoca-185®machine, by Soring
Total Wound Solutions is excited to announce the availability of the new
Sonoca-185®machine, by Soring.
The Sonoca is an ultrasonic-assisted wound debridement treatment using low working frequency of 25kHz.
It is a highly specialised piece of equipment recognised for cleansing and debriding chronic and acute wounds
via a cavitational effect in a fluid solution.
The vibrational effect is produced by the ultrasonic generator and piezo electronics in the
handpiece. Handpieces are designed with various tips to suit the wound topography and
disrupt bacterial biofilms.
This treatment removes non-viable tissue from the wound bed, similar to in-patient surgical debridement
without damaging healthy tissue and without the costs of surgery.
Low-frequency ultrasonic debridement treatment is suitable for leg ulcers (arterial and venous), diabetic foot ulcers, pressure ulcers, infected wounds, trauma wounds, burns and to prepare wounds for negative pressure therapy and skin grafts.
Call our team to discuss the treatment options and associated costs involved.